A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)

An Open-label Phase 1 Study to Evaluate Metabolism, Excretion, and Mass Balance of [¹⁴C]MK-0616 in Healthy Participants

The purpose of this study is to learn what happens to enlicitide chloride labeled with [¹⁴C] in a person's body over time. A label can be added to a study medicine to trace it in a person's body.

Inclusion Criteria:

• Is in good health.
• Has a body mass index ≥18 and ≤32 kg/m^2, inclusive.

Exclusion Criteria:

• Has a history of cancer.
• Has positive tests for hepatitis B surface antigen, hepatitis C antibodies or human immunodeficiency virus.